FMT
DRNA

First Mercantile Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

First Mercantile Trust’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,129
Closed -$117K – 898
2021
Q2 		$117K Sell
3,129
-1,019
-25% -$31.2K 0.01% 640
2021
Q1 		$106K Sell
4,148
-575
-12% -$14.7K 0.01% 665
2020
Q4 		$104K Sell
4,723
-959
-17% -$21.1K 0.01% 681
2020
Q3 		$125K Buy
5,682
+214
+4% +$4.43K 0.02% 600
2020
Q2 		$139K Buy
+5,468
New +$118K 0.02% 539

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

First Mercantile Trust's DRNA Position: Q3 2021 in Review

First Mercantile Trust sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 3,129 shares — an estimated $117K sold.

First Mercantile Trust first reported a position in DRNA in Q2 2020 and held it in 5 quarters. The position peaked at $139K in Q2 2020. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

  • First Mercantile Trust reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • First Mercantile Trust sold 3,129 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $117K.
  • First Mercantile Trust first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
  • First Mercantile Trust's Dicerna Pharmaceuticals, Inc. position peaked at $139K in Q2 2020.
  • 173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.